美国食品药品监督管理局 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "美国食品药品监督管理局" in Chinese language version.

refsWebsite

Global rank Chinese rank

25web.archive.org

1^st place

20fda.gov

447^th place

581^st place

2doi.org

2^nd place

23^rd place

2nih.gov

4^th place

5^th place

1webcitation.org

24^th place

29^th place

1akamaitech.net

low place

1dwrf.info

low place

1arizona.edu

1,592^nd place

1,417^th place

1actupny.org

low place

1archive.org

6^th place

4^th place

1abigail-alliance.org

low place

1senate.gov

758^th place

1,367^th place

1nap.edu

2,128^th place

1,765^th place

1washingtonpost.com

34^th place

129^th place

1worldcat.org

5^th place

12^th place

1thelancet.com

2,393^rd place

1,199^th place

1sina.com.cn

144^th place

3^rd place

1sohu.com

343^rd place

13^th place

abigail-alliance.org

[10]PDF（119 KiB） Abigail Alliance Citizen Petition to FDA

actupny.org

[7] （页面存档备份，存于互联网档案馆） ACT-UP NY timeline

akamaitech.net

a257.g.akamaitech.net

[2]PDF（106 KiB） Title 21 of the Code of Federal regulations

archive.org

Orlando V. The FDA's Accelerated Approval Process: Does the Pharmaceutical Industry Have Adequate Incentives for Self-Regulation?. American Journal of Law and Medicine. 1999, 25: 543–68.

arizona.edu

library.arizona.edu

[6] （页面存档备份，存于互联网档案馆） Report of Congressman Morris Udall on thalidomide and the Kefauver hearings.

doi.org

Temple R. Policy developments in regulatory approval. Statistics in Medicine. 2002, 21: 2939–2948. doi:10.1002/sim.1298.
Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020-05-22, 0 (0) [2022-05-11]. ISSN 0140-6736. PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. （原始内容存档于2022-04-01）（English）.

dwrf.info

http://www.dwrf.info/documents/recent_dev_bw_quality.pdfPDF（217 KiB）

fda.gov

FDA Centennial 1906-2006. US FDA. [2008-09-13]. （原始内容存档于2012-08-06）.
FY 2022 FDA Budget Request. FDA. [January 14, 2022]. （原始内容存档于2023-06-02）.
Meet Margaret A. Hamburg, M.D., Commissioner of Food and Drugs. US FDA. [2010-01-11]. （原始内容存档于2012-12-03）.
美國食品藥物管理局（英文縮寫“FDA”）提供這些譯文是為廣泛的國際社會讀者提供方便。. 2013-03-29 [2021-02-02]. （原始内容存档于2021-03-05）（中文（繁體））.
FDA 2008 ORA Field Activities (PDF). US FDA. [2008-09-13]. （原始内容存档 (PDF)于2009-03-26）.
Summary of FDA’s FY 2008 Budget. [2008-09-29]. （原始内容存档于2009-05-12）.
Food, Drug and Cosmetic Act Web Version [1] （页面存档备份，存于互联网档案馆）
Text of the Dietary Supplement Health and Education Act of 1994 （页面存档备份，存于互联网档案馆）. Accessed 5 Feb 2007.
MedWatch: The FDA Safety Information and Adverse Event Reporting Program[3] （页面存档备份，存于互联网档案馆）. Accessed October 9, 2007
Therapeutic Equivalence of Generic Drugs. U.S. Food and Drug Administration. 1998 [2007-10-10]. （原始内容存档于2009-05-12）.
FDA CDER Handbook: Over-the- Counter Drug Products 存档副本. [2007-10-09]. （原始内容存档于2009-05-12）. Accessed October 9, 2007
FDA/CBER - About CBER. [2008-09-29]. （原始内容存档于2009-05-11）.
2005 report of the CDRH Radiological Health Program Core GroupPDF（90.3 KiB）
[4] （页面存档备份，存于互联网档案馆） Original Text of the 1906 Food and Drugs Act and Amendments
[5] （页面存档备份，存于互联网档案馆） Milestones in U.S. Food and Drug Law History at FDA.gov
[8] （页面存档备份，存于互联网档案馆） FDA Website: Expanded Access and Expedited Approval of New Therapies Related to HIV/AIDS
存档副本. [2011-11-25]. （原始内容存档于2009-05-25）. FDA report on accelerated approval process
[9] （页面存档备份，存于互联网档案馆） FDA press release on 3TC approval

test.fda.gov

FDA's International Posts: Improving the Safety of Imported Food and Medical Products. USFDA. [April 10, 2010]. （原始内容存档于2010-08-10）.

cfsan.fda.gov

存档副本. [2009-03-18]. （原始内容存档于2009-03-09）. Overview of the Center for Food Safety and Applied Nutrition

nap.edu

books.nap.edu

[14]PDF（279 KiB） Executive Summary of the 2006 IOM Report The Future of Drug Safety: Promoting and Protecting the Health of the Public

nih.gov

ncbi.nlm.nih.gov

[11] The APPROVe study (Pubmed)
Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020-05-22, 0 (0) [2022-05-11]. ISSN 0140-6736. PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. （原始内容存档于2022-04-01）（English）.

senate.gov

[12]PDF（28.3 KiB） David Graham's 2004 testimony to Congress

sina.com.cn

tech.sina.com.cn

《拥有百年历史的血液疗法如何成为对抗COVID-19的新方法》. 新浪网. [2021-04-30]. （原始内容存档于2021-04-30）.

sohu.com

《因试剂盒缺陷被“算账”？对新冠检测工具，美国FDA说了不算了》. 搜狐网. [2021-04-30]. （原始内容存档于2021-04-30）.

thelancet.com

Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020-05-22, 0 (0) [2022-05-11]. ISSN 0140-6736. PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. （原始内容存档于2022-04-01）（English）.

washingtonpost.com

Authors retract study showing hydroxychloroquine was dangerous to hospitalized covid-19 patients. 华盛顿邮报. 2020-06-04 [2021-04-14]. （原始内容存档于2021-02-12）（英语）.

web.archive.org

FY 2022 FDA Budget Request. FDA. [January 14, 2022]. （原始内容存档于2023-06-02）.
Meet Margaret A. Hamburg, M.D., Commissioner of Food and Drugs. US FDA. [2010-01-11]. （原始内容存档于2012-12-03）.
美國食品藥物管理局（英文縮寫“FDA”）提供這些譯文是為廣泛的國際社會讀者提供方便。. 2013-03-29 [2021-02-02]. （原始内容存档于2021-03-05）（中文（繁體））.
FDA 2008 ORA Field Activities (PDF). US FDA. [2008-09-13]. （原始内容存档 (PDF)于2009-03-26）.
FDA's International Posts: Improving the Safety of Imported Food and Medical Products. USFDA. [April 10, 2010]. （原始内容存档于2010-08-10）.
Summary of FDA’s FY 2008 Budget. [2008-09-29]. （原始内容存档于2009-05-12）.
Food, Drug and Cosmetic Act Web Version [1] （页面存档备份，存于互联网档案馆）
存档副本. [2009-03-18]. （原始内容存档于2009-03-09）. Overview of the Center for Food Safety and Applied Nutrition
Text of the Dietary Supplement Health and Education Act of 1994 （页面存档备份，存于互联网档案馆）. Accessed 5 Feb 2007.
MedWatch: The FDA Safety Information and Adverse Event Reporting Program[3] （页面存档备份，存于互联网档案馆）. Accessed October 9, 2007
Therapeutic Equivalence of Generic Drugs. U.S. Food and Drug Administration. 1998 [2007-10-10]. （原始内容存档于2009-05-12）.
FDA CDER Handbook: Over-the- Counter Drug Products 存档副本. [2007-10-09]. （原始内容存档于2009-05-12）. Accessed October 9, 2007
FDA/CBER - About CBER. [2008-09-29]. （原始内容存档于2009-05-11）.
[4] （页面存档备份，存于互联网档案馆） Original Text of the 1906 Food and Drugs Act and Amendments
[5] （页面存档备份，存于互联网档案馆） Milestones in U.S. Food and Drug Law History at FDA.gov
[6] （页面存档备份，存于互联网档案馆） Report of Congressman Morris Udall on thalidomide and the Kefauver hearings.
[7] （页面存档备份，存于互联网档案馆） ACT-UP NY timeline
[8] （页面存档备份，存于互联网档案馆） FDA Website: Expanded Access and Expedited Approval of New Therapies Related to HIV/AIDS
存档副本. [2011-11-25]. （原始内容存档于2009-05-25）. FDA report on accelerated approval process
[9] （页面存档备份，存于互联网档案馆） FDA press release on 3TC approval
Henderson, Diedtra. Panel: FDA needs more power, funds. Boston Globe. 2006-09-23. [13]
Authors retract study showing hydroxychloroquine was dangerous to hospitalized covid-19 patients. 华盛顿邮报. 2020-06-04 [2021-04-14]. （原始内容存档于2021-02-12）（英语）.
Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020-05-22, 0 (0) [2022-05-11]. ISSN 0140-6736. PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. （原始内容存档于2022-04-01）（English）.
《拥有百年历史的血液疗法如何成为对抗COVID-19的新方法》. 新浪网. [2021-04-30]. （原始内容存档于2021-04-30）.
《因试剂盒缺陷被“算账”？对新冠检测工具，美国FDA说了不算了》. 搜狐网. [2021-04-30]. （原始内容存档于2021-04-30）.

webcitation.org

FDA Centennial 1906-2006. US FDA. [2008-09-13]. （原始内容存档于2012-08-06）.

worldcat.org

Mehra, Mandeep R.; Desai, Sapan S.; Ruschitzka, Frank; Patel, Amit N. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020-05-22, 0 (0) [2022-05-11]. ISSN 0140-6736. PMID 32450107. doi:10.1016/S0140-6736(20)31180-6. （原始内容存档于2022-04-01）（English）.